Use of Most Bothersome Symptom as a Coprimary Endpoint in Migraine Clinical Trials: A Post-Hoc Analysis of the Pivotal ZOTRIP Randomized, Controlled Trial

David W. Dodick, Stewart J. Tepper, Deborah I Friedman, Amy A. Gelfand, Donald J. Kellerman, Peter C. Schmidt

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Use of Most Bothersome Symptom as a Coprimary Endpoint in Migraine Clinical Trials: A Post-Hoc Analysis of the Pivotal ZOTRIP Randomized, Controlled Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences